Revance Therapeutics | RVNC - Kreditur Perdagangan



Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 3.59B 28.65B 2025-12
ALKERMES USD 102.36M 5.59M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cara Therapeutics USD 3.22M 859K 2025-12
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
J&J USD 10.46B 1.53B 2026-03
Merck USD 3.86B 541M 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
P&G USD 15.03B 143M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03